Myalgia of auxiliary muscles, head and neck
Methodology & AI Transparency ⓘ
Myalgia of auxiliary muscles, head and neck Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as M79.12, Myalgia of auxiliary muscles, head and neck falls under Chronic Pain & Nerves management, where metabolic/autoimmune neuropathy lab in Myalgia of auxiliary muscles, head and neck (M79.12: panels) establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Clinical coding for Myalgia of auxiliary muscles, head and neck uses ICD-10 M79.12 across Chronic Pain & Nerves specialty care.
- 3 Typical cash cost range: Primary evaluation for Myalgia of auxiliary muscles, head and neck incorporates metabolic/autoimmune neuropathy lab in Myalgia of auxiliary muscles, head and neck (M79.12: panels) and symptom diary review.
- 4 Top reported side effects / signs: Objective lab/clinical target for Myalgia of auxiliary muscles, head and neck: Vitamin B12 & in Myalgia of auxiliary muscles, head and neck (M79.12: Methylmalonic Acid) (B12 > 500 pg/mL (M79.12)) and hs-CRP & ESR in Myalgia of auxiliary muscles, head and neck (M79.12: Inflammatory Check).
Ask our AI Specialists anything about Myalgia of auxiliary muscles, head and neck
What Is Myalgia of auxiliary muscles, head and neck?
Designated in federal medical registries as M79.12, Myalgia of auxiliary muscles, head and neck falls under Chronic Pain & Nerves management, where metabolic/autoimmune neuropathy lab in Myalgia of auxiliary muscles, head and neck (M79.12: panels) establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in chronic pain & nerves, Myalgia of auxiliary muscles, head and neck (M79.12) involves microvascular endoneurial ischemia [Myalgia of auxiliary muscles, head and neck M79.12]. progression correlates with shifts in Vitamin B12 & in Myalgia of auxiliary muscles, head and neck (M79.12: Methylmalonic Acid) (B12 > 500 pg/mL (M79.12)).
Common Symptoms & Clinical Signs
- • Presentation of Myalgia of auxiliary muscles, head and neck (M79.12): localized nerve entrapment in Myalgia of auxiliary muscles, head and neck (M79.12: numbness or radiating)
- • Secondary Myalgia of auxiliary muscles, head and neck clinical sign: burning, electric-shock, or in Myalgia of auxiliary muscles, head and neck (M79.12: pins-and-needles pain in)
- • Symptom flares in Myalgia of auxiliary muscles, head and neck correlating with Vitamin B12 & in Myalgia of auxiliary muscles, head and neck (M79.12: Methylmalonic Acid) deviation outside B12 > 500 pg/mL (M79.12)
- • Functional chronic pain & nerves impact requiring metabolic/autoimmune neuropathy lab in Myalgia of auxiliary muscles, head and neck (M79.12: panels) evaluation (M79.12)
Myalgia of auxiliary muscles, head and neck Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M79.12 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Neuropathy, Fibromyalgia & Chronic Pain | NLM Clinical Tables |
| Diagnostic / Lab Marker: Vitamin B12 & in Myalgia of auxiliary muscles, head and neck (M79.12: Methylmalonic Acid) | B12 > 500 pg/mL (M79.12) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: hs-CRP & ESR in Myalgia of auxiliary muscles, head and neck (M79.12: Inflammatory Check) | hs-CRP < 1.0 mg/L (M79.12) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & 2-Hour in Myalgia of auxiliary muscles, head and neck (M79.12: Glucose Tolerance) | HbA1c < 5.6% (M79.12) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Myalgia of auxiliary muscles, head and neck
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Trubrexa Patch ER Trubrexa Patch ER Generic • RxCUI 2667457 | Amide Local Anesthetic | 92% | $0.9800 | $ 48.19 /mo |
| Gout Relief 3310-S (Celery Seed Medicago Sativa Whole) Gout Relief 3310-S • RxCUI RXN-B85631001 | Non-Standardized Food Allergenic Extract | 87% | $2.4100 | $ 182.02 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Myalgia of auxiliary muscles, head and neck)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a In patients with new onset polymyalgia rheumatica undergoing rapid glucocorticoid tapering, tocilizumab was superior to placebo regarding sustained glucocorticoid-free full symptom relief, time to relapse and cumulative... Annals of the rheumatic diseases • 2022-06-15 • Phase III Randomized Trial | N = 36 | 88/100 | PMID 35210264 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of Sublingual Cyclobenzaprine for the Treatment of In this phase III, randomized, controlled trial of patients with FM, treatment with TNX-102 SL was associated with significant reductions in daily pain and was safe and well tolerated. Arthritis care & research • 2023-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37165930 ↗ |
| Can This Approach Help? Inside the Latest Research on N-of-1 (single-patient) trials for statin-related In selected patients with a history of statin-related myalgia whose symptoms are difficult to evaluate, n-of-1 trials may be a useful method for determining statin tolerability. Annals of internal medicine • 2014-03-04 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 24737272 ↗ |
| Can This Approach Help? Inside the Latest Research on Long-term real-world benefits and safety of vutrisiran in hereditary Results from the HELIOS-A RTE demonstrate relative stability with only modest changes in disease activity, sustained serum TTR reductions, and an acceptable safety profile with long-term vutrisiran treatment in patients. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis • 2026-09-15 • Phase III Randomized Trial | N = 76 | 82/100 | PMID 42290201 ↗ |
| Can This Approach Help? Inside the Latest Research on Self-guided digital behavioural therapy versus active control for fibromyalgia Digital ACT was safe and efficacious compared with digital symptom tracking in managing fibromyalgia in adult patients. Lancet (London, England) • 2024-07-27 • Phase III Randomized Trial | N = 140 | 82/100 | PMID 38991582 ↗ |
Myalgia of auxiliary muscles, head and neck Patient Community & “People Like Me” Threads
Filter Myalgia of auxiliary muscles, head and neck community threads and patient logs by age, biological sex, dosage, and treatment duration.